{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(3)"],"submitter":["Xue W"],"funding":["University of Nebraska Collaboration Initiative","NICHD NIH HHS","National Institutes of Health","Mary &amp; Dick Holland Regenerative Medicine Program start-up grant and pilot grant"],"pubmed_abstract":["Cancer-associated cachexia (CAC) is a complex metabolic and behavioral syndrome with multiple manifestations that involve systemic inflammation, weight loss, and adipose lipolysis. It impacts the quality of life of patients and is the direct cause of death in 20%-30% of cancer patients. The severity of fat loss and adipose tissue remodeling negatively correlate with patients' survival outcomes. To address the mechanism of fat loss and design potential approaches to prevent the process, it will be essential to understand CAC pathophysiology through white adipose tissue models. In the present study, an engineered human white adipose tissue (eWAT) model based on three-dimensional (3D) bioprinting was developed and induced with pancreatic cancer cell-conditioned medium (CM) to mimic the status"],"journal":["Biofabrication"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9205601"],"repository":["biostudies-literature"],"pubmed_title":["3D bioprinted white adipose model for<i>in vitro</i>study of cancer-associated cachexia induced adipose tissue remodeling."],"pmcid":["PMC9205601"],"funding_grant_id":["5R01HD096042-02","R01 HD096042"],"pubmed_authors":["Xue W","Yu SY","Chung S","Kim SY","Kuss M","Duan B","Shi W","Kong Y"],"additional_accession":[]},"is_claimable":false,"name":"3D bioprinted white adipose model for<i>in vitro</i>study of cancer-associated cachexia induced adipose tissue remodeling.","description":"Cancer-associated cachexia (CAC) is a complex metabolic and behavioral syndrome with multiple manifestations that involve systemic inflammation, weight loss, and adipose lipolysis. It impacts the quality of life of patients and is the direct cause of death in 20%-30% of cancer patients. The severity of fat loss and adipose tissue remodeling negatively correlate with patients' survival outcomes. To address the mechanism of fat loss and design potential approaches to prevent the process, it will be essential to understand CAC pathophysiology through white adipose tissue models. In the present study, an engineered human white adipose tissue (eWAT) model based on three-dimensional (3D) bioprinting was developed and induced with pancreatic cancer cell-conditioned medium (CM) to mimic the status","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 May","modification":"2025-04-19T02:37:44.331Z","creation":"2025-04-07T12:58:51.9Z"},"accession":"S-EPMC9205601","cross_references":{"pubmed":["35504266"],"doi":["10.1088/1758-5090/ac6c4b"]}}